Novel patient-derived xenograft and cell line models for therapeutic testing of pediatric liver cancer

Journal of Hepatology

Volumn 65, Issue 2, 2016, Pages 325-333

  Bissig Choisat, Beatrice ^a   Kettlun Leyton, Claudia ^a   Legras, Xavier D ^a   Zorman, Barry ^b   Barzi, Mercedes ^a   Chen, Leon L ^a   Amin, Mansi D ^a   Huang, Yung Hsin ^b   Pautler, Robia G ^b,c   Hampton, Oliver A ^b   Prakash, Masand M ^c   Yang, Diane ^a,b   Borowiak, Malgorzata ^a,b,e   Muzny, Donna ^b   Doddapaneni, Harsha Vardhan ^b   Hu, Jianhong ^b   Shi, Yan ^b,c   Gaber, M Waleed ^b,c   Hicks, M John ^c   Thompson, Patrick A ^b   Lu, Yiling ^d   Mills, Gordon B ^d   Finegold, Milton ^b,c   Goss, John A ^b,c   Parsons, D Williams ^b   Vasudevan, Sanjeev A ^b,c   Sumazin, Pavel ^b   López Terrada, Dolores ^b,c   Bissig, Karl Dimiter ^a,b   more..

^a CENTER FOR CELL AND GENE THERAPY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c TEXAS CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e McNair Medical Institute   (United States)

Author keywords

Patient derived xenograft; Pediatric liver cancer; Therapeutic testing

Indexed keywords

ALPHA FETOPROTEIN; BETA CATENIN; BUPARLISIB; EDOXUDINE; FUMARYLACETOACETASE; GLYPICAN 3; HEMOGLOBIN F; HUMAN ALBUMIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; RNA; TRAMETINIB; VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B6 CELL LINE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER MODEL; CANCER PATIENT; CANCER STEM CELL; CANCER SURGERY; CHEMOSENSITIVITY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENOME; HEPATOBLASTOMA; HEPG2 CELL LINE; HEPT1 CELL LINE; HUH6 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CANCER; LIVER CANCER CELL LINE; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER TRANSPLANTATION; MALE; MOUSE; NONHUMAN; PATIENT DERIVED TUMOR XENOGRAFT; PEDIATRIC SURGERY; PRESCHOOL CHILD; PRIMARY TUMOR; PRIORITY JOURNAL; RNA SEQUENCE; SCHOOL CHILD; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; ANIMAL; CANCER TRANSPLANTATION; DISEASE MODEL; DRUG SCREENING; LIVER TUMOR; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CHILD; DISEASE MODELS, ANIMAL; HETEROGRAFTS; HUMANS; LIVER NEOPLASMS; MICE; NEOPLASM TRANSPLANTATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84969645459     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2016.04.009     Document Type: Article

References (35)

1. [1] Bulterys, M., Goodman, M.T., Smith, M.A., Buckley, J.D., Hepatic tumors. Ries, L.A.G., Smith, M.A., Gurney, J.G., Linet, M., Tamra, T., Young, J.L., Bunin, G.R., (eds.) Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1995, 1999, National Cancer Institute, SEER Program. NIH, Bethesda, 91–98.
2. [2] Meyers, R.L., Aronson, D.C., Von Schweinitz, D., Zimmermann, A., Malogolowkin, M.H., Pediatric liver tumors. Pizzo, P.A., Poplack, D.G., (eds.) Principles and practice of pediatric oncology, 6th ed., 2011, Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, 1531.
3. [3] Ansell, P., Mitchell, C.D., Roman, E., Simpson, J., Birch, J.M., Eden, T.O., Relationships between perinatal and maternal characteristics and hepatoblastoma: a report from the UKCCS. Eur J Cancer 41 (2005), 741–748.
4. [4] Ikeda, H., Matsuyama, S., Tanimura, M., Association between hepatoblastoma and very low birth weight: a trend or a chance?. J Pediatr 130 (1997), 557–560.
5. [5] Feusner, J., Buckley, J., Robison, L., Ross, J., Van Tornout, J., Prematurity and hepatoblastoma: more than just an association?. J Pediatr 133 (1998), 585–586.
6. [6] Engstrom, W., Lindham, S., Schofield, P., Wiedemann-Beckwith syndrome. Eur J Pediatr 147 (1988), 450–457.
7. [7] Kingston, J.E., Herbert, A., Draper, G.J., Mann, J.R., Association between hepatoblastoma and polyposis coli. Arch Dis Child 58 (1983), 959–962.
8. [8] Mokkapati, S., Niopek, K., Huang, L., Cunniff, K.J., Ruteshouser, E.C., deCaestecker, M., et al. Beta-catenin activation in a novel liver progenitor cell type is sufficient to cause hepatocellular carcinoma and hepatoblastoma. Cancer Res 74 (2014), 4515–4525.
9. [9] Shachaf, C.M., Kopelman, A.M., Arvanitis, C., Karlsson, A., Beer, S., Mandl, S., et al. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 431 (2004), 1112–1117.
10. [10] Hata, Y., Uchino, J., Sato, K., Sasaki, F., Une, Y., Naito, H., et al. Establishment of an experimental model of human hepatoblastoma. Cancer 50 (1982), 97–101.
11. [11] Desdouets, C., Fabre, M., Gauthier, F., Brechot, C., Sobczak-Thepot, J., Proliferation and differentiation of a human hepatoblastoma transplanted in the Nude mouse. J Hepatol 23 (1995), 569–577.
12. [12] Fuchs, J., Schmidt, D., Pietsch, T., Miller, K., von Schweinitz, D., Successful transplantation of human hepatoblastoma into immunodeficient mice. J Pediatr Surg 31 (1996), 1241–1246.
13. [13] Ellerkamp, V., Armeanu-Ebinger, S., Wenz, J., Warmann, S.W., Schafer, J., Ruck, P., et al. Successful establishment of an orthotopic hepatoblastoma in vivo model in NOD/LtSz-scid IL2Rgammanull mice. PLoS One, 6, 2011, e23419.
14. [14] Doi, I., Establishment of a cell line and its clonal sublines from a patient with hepatoblastoma. Gann 67 (1976), 1–10.
15. [15] Aden, D.P., Fogel, A., Plotkin, S., Damjanov, I., Knowles, B.B., Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature 282 (1979), 615–616.
16. [16] Pietsch, T., Fonatsch, C., Albrecht, S., Maschek, H., Wolf, H.K., von Schweinitz, D., Characterization of the continuous cell line HepT1 derived from a human hepatoblastoma. Lab Invest 74 (1996), 809–818.
17. [17] Weber, R.G., Pietsch, T., von Schweinitz, D., Lichter, P., Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome. Am J Pathol 157 (2000), 571–578.
18. [18] Chen, T.T., Rakheja, D., Hung, J.Y., Hornsby, P.J., Tabaczewski, P., Malogolowkin, M., et al. Establishment and characterization of a cancer cell line derived from an aggressive childhood liver tumor. Pediatr Blood Cancer 53 (2009), 1040–1047.
19. [19] Manchester, K.M., Warren, D.J., Erlandson, R.A., Wheatley, J.M., La Quaglia, M.P., Establishment and characterization of a novel hepatoblastoma-derived cell line. J Pediatr Surg 30 (1995), 553–558.
20. [20] S. Scheil, S. Hagen, Bruderlein, S., Leuschner, I., Behnisch, W., Moller, P., Two novel in vitro human hepatoblastoma models, HepU1 and HepU2, are highly characteristic of fetal-embryonal differentiation in hepatoblastoma. Int J Cancer 105 (2003), 347–352.
21. [21] Bissig, K.D., Le, T.T., Woods, N.B., Verma, I.M., Repopulation of adult and neonatal mice with human hepatocytes: a chimeric animal model. Proc Natl Acad Sci U S A 104 (2007), 20507–20511.
22. [22] Shultz, L.D., Lyons, B.L., Burzenski, L.M., Gott, B., Chen, X., Chaleff, S., et al. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol 174 (2005), 6477–6489.
23. [23] M. Ito, H. Hiramatsu, Kobayashi, K., Suzue, K., Kawahata, M., Hioki, K., et al. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 100 (2002), 3175–3182.
24. [24] Yahata, T., Ando, K., Nakamura, Y., Ueyama, Y., Shimamura, K., Tamaoki, N., et al. Functional human T lymphocyte development from cord blood CD34+ cells in nonobese diabetic/Shi-scid, IL-2 receptor gamma null mice. J Immunol 169 (2002), 204–209.
25. [25] Azuma, H., Paulk, N., Ranade, A., Dorrell, C., Al-Dhalimy, M., Ellis, E., et al. Robust expansion of human hepatocytes in Fah(-/-)/Rag2(-/-)/Il2rg(-/-) mice. Nat Biotechnol 25 (2007), 903–910.
26. [26] Lopez-Terrada, D., Alaggio, R., de Davila, M.T., Czauderna, P., Hiyama, E., Katzenstein, H., et al. Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium. Mod Pathol 27 (2014), 472–491.
27. [27] Scollon, S., Bergstrom, K., Kerstein, R.A., Wang, T., Hilsenbeck, S.G., Ramamurthy, U., et al. Obtaining informed consent for clinical tumor and germline exome sequencing of newly diagnosed childhood cancer patients. Genome Med, 6, 2014, 69.
28. [28] Gopal, Y.N., Deng, W., Woodman, S.E., Komurov, K., Ram, P., Smith, P.D., et al. Basal and treatment-induced activation of AKT mediates resistance to cell death by AZD6244 (ARRY-142886) in Braf-mutant human cutaneous melanoma cells. Cancer Res 70 (2010), 8736–8747.
29. [29] Renshaw, J., Taylor, K.R., Bishop, R., Valenti, M., De Haven, Brandon A., Gowan, S., et al. Dual blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) pathways synergistically inhibits rhabdomyosarcoma cell growth in vitro and in vivo. Clin Cancer Res 19 (2013), 5940–5951.
30. [30] Kerbel, R.S., Cornil, I., Theodorescu, D., Importance of orthotopic transplantation procedures in assessing the effects of transfected genes on human tumor growth and metastasis. Cancer Metastasis Rev 10 (1991), 201–215.
31. [31] Killion, J.J., Radinsky, R., Fidler, I.J., Orthotopic models are necessary to predict therapy of transplantable tumors in mice. Cancer Metastasis Rev 17 (1998), 279–284.
32. [32] Kuo, T.H., Kubota, T., Watanabe, M., Furukawa, T., Kase, S., Tanino, H., et al. Site-specific chemosensitivity of human small-cell lung carcinoma growing orthotopically compared to subcutaneously in SCID mice: the importance of orthotopic models to obtain relevant drug evaluation data. Anticancer Res 13 (1993), 627–630.
33. [33] T. Yang, J.H. Lu, C. Lin, S. Shi, Chen, T.H., Zhao, R.H., et al. Concomitant lung metastasis in patients with advanced hepatocellular carcinoma. World J Gastroenterol 18 (2012), 2533–2539.
34. [34] Uchiyama, M., Iwafuchi, M., Naito, M., Yagi, M., Iinuma, Y., Kanada, S., et al. A study of therapy for pediatric hepatoblastoma: prevention and treatment of pulmonary metastasis. Eur J Pediatr Surg 9 (1999), 142–145.
35. [35] Dangles-Marie, V., Pocard, M., Richon, S., Weiswald, L.B., Assayag, F., Saulnier, P., et al. Establishment of human colon cancer cell lines from fresh tumors versus xenografts: comparison of success rate and cell line features. Cancer Res 67 (2007), 398–407.